Historique de carrière de Fernando Doñate
Anciens postes connus de Fernando Doñate
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Attenuon, LLC | Corporate Officer/Principal | - | - |
Proacta, Inc.
 Proacta, Inc. BiotechnologyHealth Technology Proacta, Inc. develops drugs to treat cancer. It is developing a new generation of hypoxia-activated prodrug compounds to treat cancer. The firm’s lead product PR610, is a proprietary, hypoxia-activated prodrug with potential antineoplastic activity. The company was founded in 2001 by William A. Denny, Amato J. Giaccia, William Robert Wilson and Martin J. Brown and is headquartered in La Jolla, CA. | Directeur Technique/Scientifique/R&D | 22/02/2010 | - |
| Corporate Officer/Principal | 01/03/2008 | 22/02/2010 |
Formation de Fernando Doñate
| University of Missouri | Doctorate Degree |
| Universidad Complutense de Madrid | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Espagne | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Proacta, Inc.
Proacta, Inc. BiotechnologyHealth Technology Proacta, Inc. develops drugs to treat cancer. It is developing a new generation of hypoxia-activated prodrug compounds to treat cancer. The firm’s lead product PR610, is a proprietary, hypoxia-activated prodrug with potential antineoplastic activity. The company was founded in 2001 by William A. Denny, Amato J. Giaccia, William Robert Wilson and Martin J. Brown and is headquartered in La Jolla, CA. | Health Technology |
| Attenuon, LLC |
- Bourse
- Insiders
- Fernando Doñate
- Expérience
